Collaboration between Paraza Pharma and Université de Montréal
Paraza is pleased to announce a new collaboration with three research groups of the Department of Chemistry of the Université de Montréal. Paraza will contribute financially and personally to selected research projects from the groups of Professors Samy Cecioni, Hélène Lebel, and Shawn Collins.
2023 Leading Edge Of Cancer Research Symposium
Paraza Pharma will be attending the 2023 Leading Edge Of Cancer Research Symposium hosted by MD Anderson in Houston, Texas – November 16 & 17, 2023. Come meet our team !
Paraza Pharma is a proud sponsor of QOMSBOC 2023
Paraza Pharma is a proud sponsor of QOMSBOC 2023 which will be held at Concordia University from November 10-12, 2023 at the John Molson School of Business. We look forward to seeing you there !
Insights Success Magazine – Arshad Siddiqui
Arshad Siddiqui, President & CEO of Paraza Pharma featured in the October issue of Insights Success Magazine – Most Influential Business Leaders to Follow in Canada 2023.
Publication
Alberto dos Santos Pereira, a Principal Scientist within our Analytical Chemistry group, has published a study in which he explored the impact of the introduction of water and protic solvents into the mobile phase (replacing acetonitrile) on the efficiency of chiral separations with polysaccharide-based columns in the Journal of Separation Science. This demonstrates the high-quality of analytical support we offer to our collaborators.
Paraza Lecture Series – Dr. Louis-Charles Campeau, Merck
As part of our 2023 Paraza Lecture Series, we wish to welcome Louis-Charles Campeau, Head of Small Molecule Process R&D at Merck on Nov. 10th, 2023.
Paraza and Mila announce a partnership to advance AI in Drug Discovery
Paraza is committed to providing its clients with innovative and effective drug discovery services and has been at the forefront of incorporating novel approaches and technologies, including the practical implementation of artificial intelligence (AI) in its drug discovery processes.
Paraza’s academic-industrial collaborative initiative with the University of Ottawa
Paraza is proud to support the work of young researchers through our Academic-Industrial Collaborative Initiative.
Paraza Pharma Inc. is pleased to announce a recent publication
Nickel-Catalyzed N‑Arylation of Sulfinamides: A Comparative Study versus Analogous Sulfonamide Cross-Couplings Organometallics. 2023, 42, 1704
Oral & poster awardees for the Paraza Pharma Symposium on Organic Chemistry
We would like to extend our sincere appreciation to the fifty graduate students and post-docs that attended the Paraza Pharma Symposium on Organic Chemistry last week. Your presence and active participation contributed immensely to the success of the event.